Bristol-Myers Squibb has filed a motion with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to send dozens of lawsuits alleging compulsive gambling side effects from the antipsychotic drug Abilify (generic: aripiprazole) to federal court in Pensacola, Florida.
Free Confidential Lawsuit Evaluation: If you or a loved one was injured by Abilify, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the Problem?
October 3, 2016 – Bristol-Myers and co-defendant Otsuka Pharmaceutical Co., consenting to a plaintiff’s motion to transfer the cases to Florida, stressed during a hearing with the JPML that U.S. District Judge Margaret Catherine Rodgers is already handling 2 Abilify gambling cases in federal court in Pensacola, and has “taken the bull by the horns” by consulting with state court judges handling related complaints.
Bristol-Myers and Otsuka rejected claims made by a self-described rogue plaintiff seeking to centralize the cases in Massachusetts that Pensacola is not an ideal venue for the MDL. The defendants contend that the Northern District of Florida makes sense since 13 Abilify lawsuits have already been consolidated in New Jersey state court, and that other plaintiffs have consented to the proposed jurisdiction.
Abilify is currently the best-selling antipsychotic drug in the U.S. However, due to the way the medication affects the brain, patients may develop impulse control problems that cause them to gamble uncontrollably and display other pathological behaviors. In August 2016, the U.S. Food & Drug Administration (FDA) revised the labeling of Abilify to include a warning (PDF) regarding “pathological gambling and other compulsive behaviors.” The new labeling indicates that patients may not recognize such behaviors as abnormal, counsels doctors to inquire with patients about such behaviors, and recommends discontinuation or dose reduction if these behaviors appear.
Abilify lawsuits allege that Bristol-Myers and Otsuka failed to adequately warn the public and medical community of the drug’s potential to cause compulsive behavior problems. Consolidation of the cases allows all pending federal complaints, as well as the many that are likely to be filed in the coming weeks and months, to undergo coordinated pretrial proceedings, including discovery and motions practice. This promotes judicial efficiency, streamlines the litigation process, and serves the best interest of all parties involved. The litigation is In Re: Abilify Compulsive Behavior Products Liability Litigation – MDL No. 2734.
Do I Have an Abilify Gambling Lawsuit?
The Class Action Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Abilify lawsuits. We are handling individual litigation nationwide and currently accepting new compulsive gambling cases in all 50 states.
Free Case Evaluation: Again, if you were injured by the side effects of Abilify, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.